Back to discover
Disease

Spinocerebellar ataxia type 6

Late-stage therapeutic development

Also known as CACNA1A autosomal dominant cerebellar ataxia type III, SCA6, autosomal dominant cerebellar ataxia type III caused by mutation in CACNA1A, spinocerebellar ataxia 6.

4
Clinical trials
1
Associated genes
1
Related proteins

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial with recent milestones (1 completed or reporting results).
Clinical Milestones1View
Results posted 1
Activity timeline1

Clinical trials

3 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
4
All trials
2
Active
2
Late-stage
0
Completed
Late-stage studies

A Phase III, Long-Term, Randomized, Double-blind, Placebo-controlled Trial of Troriluzole in Adult Participants With Spinocerebellar Ataxia.

Phase 3 · Active, not recruiting · Biohaven Pharmaceuticals, Inc.

An Open Pilot Trial of BHV-4157 in Adult Subjects With Cerebellar Ataxia

Phase 3 · Active, not recruiting · University of California, Los Angeles

Associated genes

1 match

Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.

CACNA1A0.77

Disease biology

1 match

Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.

Voltage-dependent P/Q-type calcium channel subunit alpha-1Avia CACNA1A0.77

Reference

Authoritative identity, definition & identifiers.

Synonyms

CACNA1A autosomal dominant cerebellar ataxia type III, SCA6, autosomal dominant cerebellar ataxia type III caused by mutation in CACNA1A, spinocerebellar ataxia 6

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.